Press release
Huateng Pharma Develops Caronic Anhydride & Derivatives As Paxlovid Intermediates
This NEJM article published viral load data that Paxlovid reduced viral load by 0.868 log10 compared to controls for 5 days of treatment, which equates to a remarkable 7.38-fold reduction in viral load. This pivotal study (NCT04960202) enrolled 2,246 patients with COVID-19, 1,120 received Paxlovid and 1,126 received placebo. Interim analysis showed that 28 days after receiving treatment, Paxlovid reduced the risk of hospitalization and death by 89.1% (p
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com/
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818
Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Huateng Pharma Develops Caronic Anhydride & Derivatives As Paxlovid Intermediates here
News-ID: 2586559 • Views: …
More Releases from Hunan Huateng Pharmaceutical Co. Ltd.
Huateng Pharma Supplies Minoxidil Intermediate 2,4-Diamino-6-chloropyrimidine (C …
Minoxidil was first introduced by Upjohn Company of the United States, and was first used as an oral drug for the treatment of refractory hypertension in the 1970s. In later clinical applications, doctors observed hair regrowth and generalized excessive hair in balding patients, which led to the development of minoxidil preparations.
Minoxidil can increase local blood supply, stimulate the proliferation and differentiation of hair follicle epithelial cells, so as to promote…
Huateng Pharma Supplies Anti-diabetic API Intermediates With Huge Stock
Diabetes is a serious chronic disease characterized by elevated blood sugar concentrations associated with the effects of abnormal beta cell biology on insulin action. Diabetes occurs when the pancreas does not produce enough insulin or the body does not use the insulin it does produce efficiently.
The most common forms of diabetes are type 1 diabetes and type 2 diabetes. Type 1 diabetes is characterized by insufficient insulin production and…
Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of …
Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer - that is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally.
The majority…
ADC Drugs For HER2 Positive Breast Cancer
According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly invasive and has poor prognosis.
Although more drug…
More Releases for Paxlovid
COVID-19 Therapeutics Market Anticipated to Contract to More Than US$16.2 Billio …
The global COVID-19 therapeutics market, valued at US$30.7 billion in 2021, is expected to undergo significant contraction over the next decade. It is projected to decline at a compound annual growth rate (CAGR) of -8.3% from 2022 to 2031, reaching more than US$16.2 billion by the end of 2031. This notable downturn reflects the evolving landscape of the pandemic, driven by widespread vaccination, reduced acute demand for treatments, and shifting…
Prescription Drugs Market Growth, Trends, and Key Insights | Global Industry Ana …
The Global Prescription Drugs Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Prescription Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive…
Paxlovid API Market 2023 Porter's Five Forces Analysis, Research Approach, Consu …
The research study conducted by Report Ocean on the "Paxlovid API Market" spans over 100 pages and delves into various facets of this market. It analyses the business strategies adopted by emerging industry players, examines the geographical scope, dissects market segments, evaluates the product landscape, and investigates price and cost structures. This research report facilitates market segmentation based on the latest Market trends, geographical market, and technological advancements. Each section…
Oral Antiviral Medicines for COVID-19 Market Optimizing Storage and Distribution …
The Global Oral Antiviral Medicines for COVID-19 market report offers several noteworthy takeaways. Firstly, it highlights a promising outlook for the market's future growth, with a focus on key sectors and significant global players. The Oral Antiviral Medicines for COVID-19 market report thoroughly analyzes changing trends within the industry and different market dynamics. It provides a comprehensive breakdown of market segments and sub-segments, offering valuable insights into market diversification. the…
Covid-19 Treatment Medicine Market Forecast By Type And By Application With Deta …
Los Angeles, United States December 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Covid-19 Treatment Medicine market. It sheds light on how the global Covid-19 Treatment Medicine market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of…
Huateng Pharma Supplies Ensitrelvir Intermeidates Against COVID-19
Ensitrelvir (code name S-217622, brand name Xocova), is a new inhibitor of the SARS-CoV-2 major protease (Mpro), also known as 3C-like protease, has been shown to reduce the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters. In cells, low nanomolar to sub-micromolar doses of Ensitrelvir suppress viral growth. In hamsters, oral treatment of Ensitrelvir showed excellent pharmacokinetic qualities and hastened recovery from acute SARS-CoV-2 infection.
Ensitrelvir…
